Clinics and Research in Hepatology and Gastroenterology

"Shared Genes, Different Clinical Challenges: A New Likely Pathogenic Variant in the ABCB4 Gene"
Correia SR, Guedes TP, Da Silva JD, Tkachenko N and Pedroto I
Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE
Allaire M, Garcia H, Meyblum L, Mouri S, Spitzer E, Goumard C, Lucidarme O, Rudler M, Scatton O, Roux C, Wagner M and Thabut D
. We aimed to investigate the parameters associated with portal hypertension (PHT)-related complications occurrence in hepatocellular carcinoma (HCC) patients treated by transarterial chemoembolization (TACE), with a focus on non-selective beta blockers (NSBBs) due to their impact on preventing liver decompensation.
Syphilitic granulomatous hepatitis
Durand M, Cholley LM, Morgand M and Arrivé L
Prolonged survival in women with hepatocellular carcinoma: A French observational study
Busso C, Nault JC, Layese R, Demory A, Blaise L, Nkontchou G, Grando V, Nahon P and Ganne-Carrié N
Less than 25 % of hepatocellular carcinoma (HCC) occurs in women, in whom prognosis could be better. Due to the lack of date in Europe, this study aims to assess survival of patients with HCC according sex in a tertiary French liver center.
Superiority of Frailty Over Age in Predicting Outcomes Among Clostridium Difficile Patients: Evidence from National Data
Jaan A, Farooq U, Alayoub AA, Nadeem H, Zahid E, Dhawan A, Thor S and Rahman AU
Clostridium difficile infection (CDI) has become a significant healthcare issue with increasing morbidity and mortality in the US and Europe. Frailty, characterized by reduced physical reserves and resistance to stressors, is linked to poor outcomes but its impact on CDI patients remains underexplored. This study seeks to address this gap through a nationwide analysis.
A Review Investigating delays in Crohn's disease diagnosis
Souaid C, Fares E, Primard P, Macaigne G, Hajj WE and Nahon S
Crohn's disease (CD) is a chronic inflammatory condition of the gastrointestinal tract where early diagnosis and timely, appropriate management are essential to prevent severe complications and reduce the need for surgery. This review sought to investigate factors contributing to diagnostic delays in CD, which typically ranged from 5 to 16 months. Delays were often due to nonspecific symptoms that could be mistaken for irritable bowel syndrome (IBS) and were influenced by various factors including age, education level, smoking, NSAID use, and disease characteristics like isolated ileal involvement. Healthcare system disparities also played a significant role, with delays varying by access to care. The review highlighted that delayed diagnosis was linked to worse disease outcomes, such as increased severity and complications, and underscored the importance of early intervention combined with timely management. Strategies to mitigate delays included implementing red flag tools, using inflammatory biomarkers like fecal calprotectin, and enhancing public and healthcare provider awareness. Addressing these factors and improving referral pathways and healthcare system efficiencies were crucial for enhancing early diagnosis and patient outcomes.
Neighborhood opportunity is associated with completion of hepatocellular carcinoma surveillance prior to the diagnosis of hepatocellular carcinoma in patients with cirrhosis
Jiang J, Bouquet E, Kweon Y, Elsaid MI, Diaz DA, Conteh L and Sobotka LA
The Ohio Opportunity Index (OOI) is a multidimensional metric used to quantify neighborhood-level resources to access a wide array of factors that influence health. This study examined the relationship between neighborhood opportunity and completion of guideline-concordant hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Adenosquamous intrahepatic cholangiocarcinoma in a patient with primary sclerosing cholangitis and ulcerative colitis
Rodrigues IC, Dibombe L, Guillouche P, Matysiak-Budnik T, Bouda D and Touchefeu Y
Safety and efficacy of the enhanced recovery after surgery protocol in hepatectomy for liver cancer
Lv Q, Xiang YC, Qiu YY and Xiang Z
The aim of this research was to evaluate the efficacy and safety of enhanced recovery after surgery (ERAS) protocol in hepatectomy patients with liver cancer.
Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mm
Wang J, Zhang X, Chen K, Liang Y, Liu Y, Jiang Z, He Y, Chen J and Liu J
The optimal histologically complete (R0) resection methods of endoscopy for rectal neuroendocrine tumor (NET) ≤ 10 mm remains controversial. We aimed to assess the optimal endoscopic treatments for NETs.
Propensity score matching-based analysis of the effect of corticosteroids in treating severe drug-induced liver injury
Wu H, Yan W, Liu K, Jing J and Ye W
There is no conventional treatment for patients with severe drug-induced liver injury (DILI) except for discontinuation of liver injury drugs and symptomatic supportive therapy. Opinions on whether corticosteroids can be used to treat severe DILI are conflicting, and most of the relevant clinical studies are case reports or retrospective studies, which still need to be supported by high-level evidence-based medical studies. This study aimed to evaluate the effect and tolerance of corticosteroids in patients with severe DILI. Risk factors associated with patient failure to cure were also explored.
Therapeutic effects of fecal microbial transplantation on alcoholic liver injury in rat models
Zhang Y, Li P, Chen B and Zheng R
Disruption of gut microbiota is closely related to the progression of alcoholic liver disease (ALD). This study aimed to explore the therapeutic effect of fecal microbiota transplantation (FMT) in ALD rats using a combination of microbiological and metabolomic techniques.
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease
Alonso-Gomez M, Charlois AL, Cotte E, Gay C, Danion P, Malezieux E, Altwegg R, Boschetti G and Nancey S
Real life data about the long-term efficacy of darvadstrocel for treating perianal fistulas in Crohn's disease (CD) remain scarce.
The prevalence of small intestine bacterial overgrowth in irritable bowel syndrome is much higher with lactulose than glucose breath test: Results of a retrospective monocentric study
Mion F, Subtil F, Machon C, Roman S and Mialon A
Glucose (GBT) and lactulose (LBT) breath tests have been recommended for the diagnosis of small intestinal bacterial overgrowth (SIBO). LBT may yield a higher prevalence of SIBO diagnosis, because of its limited small bowel absorption, and therefore colonic fermentation. The aim of this retrospective study was to confirm this hypothesis, in irritable bowel syndrome patients (IBS).
Efficacy of gastric per-oral endoscopic myotomy remains similar after failure of interventional techniques in refractory gastroparesis
Chartier M, Duboc H, Moszkowicz D, Dior M, Le Gall M, Coffin B and Soliman H
Gastric per-oral endoscopic myotomy (G-POEM) is a new therapeutic option for the treatment of refractory gastroparesis. However, the outcome of G-POEM after the failure of gastric electrical stimulation (GES) or other pylorus-targeting therapies has been poorly reported.
Intra- and inter-patient diversity in hepatocellular carcinoma based on phosphorylation profiles-A pilot study in a single institution
Toriguchi K, Hatano E, Sudo M, Nakamura I and Hirono S
Recent studies have addressed the efficacy of targeted drugs against hepatocellular carcinoma. However, most tumors escape a single kinase inhibition; co-inhibition of additional signaling pathways re-sensitizes resistant cancer cells to targeted drugs, thus reinforcing the importance of combination therapy for drug-resistant tumors. This study aimed to clarify the phosphorylation profiles of representative cancer-related tyrosine kinases in hepatocellular carcinoma to focus on potential therapeutic targets and to investigate the possibility of expanding combination therapy options using targeted drugs.
Predictive value of hepatic venous pressure gradient in cirrhotic portal vein thrombosis development
Zhong H, Lu S, Xu M, Liu N, Ye W and Yang Y
There are lots of risk factors reported for cirrhotic portal vein thrombosis (PVT) development, however, the relationship between hepatic venous pressure gradient (HVPG) and PVT development remains unclear.
The clinical prognostic risk stratification system for HIV infected hepatocellular carcinoma
Chen Y, Zhao H, Wang Y, Liu B, Chen Z, Tao Y, Xun Y, Yang H, Liu R, Feng L, Liu X, Li H, Wang S, Liao B, Zhao D, He H and You H
Patients with human immunodeficiency virus (HIV) are more susceptible to liver cancer because of their compromised immune system. There is no specific prognostic model for HIV-infected hepatocellular carcinoma (HCC) patients.
Ascites and psychiatric symptoms associated with syphilis
Zhang H, Liu H, Tang Q and Zhang M
Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study)
Laharie D, Bouhnik Y, Vuitton L, Biron A, Pierron G, Brault Y, Assing M, Bouzidi A, Amiot A and Nancey S
ReFLECT was a French, prospective, multicenter, observational cohort study evaluating the effectiveness and safety of the infliximab (IFX) biosimilar CT-P13 in a real-world setting. Here, we describe the results for adults with inflammatory bowel disease (IBD).
ZNF143-mediated upregulation of MEX3C promotes hepatocellular carcinoma progression
Zhang L, Dang N, Wang J, Zhang W, Hu X, Jiang B, Zhao D, Liu F and Yuan H
Microvascular invasion is strongly associated with aggressive tumor behavior and recurrence in hepatocellular carcinoma (HCC) patients. Zinc finger protein 143(ZNF143) is a transcription factor involved in a wide variety of physiological and developmental processes. This study primarily focuses on the exact biological role and mechanism of ZNF143 in HCC migration and invasion.